EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation

Thabata Muta, Riya Khetan, Yunmei Song iD, Sanjay Garg iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Thabata Muta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pharmaceutical Innovation (CPI), Clinical & Health Science, University of South Australia, Adelaide, SA 5000, Australia. Hauptthemen laut MEDLINE: Cannabidiol, Phospholipids, Water, Drug Delivery Systems. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of South Australia, MedTEC Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) has demonstrated therapeutic potential in treating epilepsy, multiple sclerosis, Alzheimer’s, Parkinson’s, and Crohn’s diseases. Despite its promising effects and analgesic, anti-inflammatory, and anxiolytic properties, oral CBD’s full potential is hindered by poor water solubility (0.7–10 μg/mL), low permeability, and chemical instability. This study aimed to enhance CBD’s dissolution, stability, and gastrointestinal (GI) permeability by forming a CBD–phospholipid complex (CBD-PLC). We hypothesised that CBD-PLC would enhance CBD’s hydrophilicity, thus improving GI barrier permeability. This study involved screening an optimal phospholipid (PL) using a Design of Experiments (DoE) approach to prepare CBD-PLC with nanosized droplets (194.3 nm). Dissolution studies revealed significantly enhanced release rates for CBD-PLC—44.7% at 2 h and 67.1% at 3 h—compared to 0% for pure CBD and 7.2% for a physical mixture (PM). Cellular uptake studies showed that at 30 µM, CBD-PLC exhibited 32.7% higher apparent permeability coefficients (Papp), nearly doubling at 40 µM compared to pure CBD. Cytotoxicity tests confirmed safety over 24 h, while 12-month stability tests demonstrated consistent performance under varied conditions. The results indicate that CBD-PLC improves CBD’s solubility, permeability, and stability, offering a promising strategy to address the limitations of oral CBD delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolPhospholipidsWaterDrug Delivery SystemsSolubilityPermeabilityHumansAnimals

Stichwörter der Autor:innen

cannabidiol (CBD)controlled releaselipid-based nanotechnologyoral deliveryphospholipid complexation (PLC)water solubility

Substanzen

CannabidiolPhospholipidsWater

Autor:innen und Institutionen

  • Centre for Pharmaceutical Innovation (CPI), Clinical & Health Science, University of South Australia, Adelaide, SA 5000, Australia.

ORCID-Profile: Yunmei Song, Sanjay Garg

Förderung

  • University of South Australia, MedTEC Pharma

Zitieren

APA

Muta, T., Khetan, R., Song, Y., & Garg, S. (2025). Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062647

Vancouver

Muta T, Khetan R, Song Y, Garg S. Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062647

BibTeX
@article{Muta2025,
  author = {Muta, Thabata and Khetan, Riya and Song, Yunmei and Garg, Sanjay},
  title = {Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062647}
}
Kostenlos starten →